BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8621427)

  • 1. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
    Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
    J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
    Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
    Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the VEGF binding site on the Flt-1 receptor.
    Herley MT; Yu Y; Whitney RG; Sato JD
    Biochem Biophys Res Commun; 1999 Sep; 262(3):731-8. PubMed ID: 10471394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
    Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
    J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S; Fidder H; Neufeld G; Klagsbrun M
    J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
    J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E; Schiller P; Cao Y; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
    Park JE; Chen HH; Winer J; Houck KA; Ferrara N
    J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.
    Muller YA; Christinger HW; Keyt BA; de Vos AM
    Structure; 1997 Oct; 5(10):1325-38. PubMed ID: 9351807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).
    Tanaka K; Yamaguchi S; Sawano A; Shibuya M
    Jpn J Cancer Res; 1997 Sep; 88(9):867-76. PubMed ID: 9369935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.
    Gille H; Kowalski J; Yu L; Chen H; Pisabarro MT; Davis-Smyth T; Ferrara N
    EMBO J; 2000 Aug; 19(15):4064-73. PubMed ID: 10921887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites.
    Cunningham SA; Arrate MP; Brock TA; Waxham MN
    Biochem Biophys Res Commun; 1997 Nov; 240(3):635-9. PubMed ID: 9398617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.
    Gerber HP; McMurtrey A; Kowalski J; Yan M; Keyt BA; Dixit V; Ferrara N
    J Biol Chem; 1998 Nov; 273(46):30336-43. PubMed ID: 9804796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
    Clauss M; Weich H; Breier G; Knies U; Röckl W; Waltenberger J; Risau W
    J Biol Chem; 1996 Jul; 271(30):17629-34. PubMed ID: 8663424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.
    Keyt BA; Berleau LT; Nguyen HV; Chen H; Heinsohn H; Vandlen R; Ferrara N
    J Biol Chem; 1996 Mar; 271(13):7788-95. PubMed ID: 8631822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes.
    Takagi H; King GL; Aiello LP
    Diabetes; 1996 Aug; 45(8):1016-23. PubMed ID: 8690146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H; King GL; Ferrara N; Aiello LP
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).
    Yamane A; Seetharam L; Yamaguchi S; Gotoh N; Takahashi T; Neufeld G; Shibuya M
    Oncogene; 1994 Sep; 9(9):2683-90. PubMed ID: 8058332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
    Siemeister G; Schirner M; Reusch P; Barleon B; Marmé D; Martiny-Baron G
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4625-9. PubMed ID: 9539788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.